REST-driven upregulation of SFXN3 promotes AML progression via Wnt/β-catenin activation and confers decitabine resistance
One of the most diverse types of blood cancer is acute myeloid leukemia, or AML, and there remains an urgent need to identify novel molecular targets for its diagnosis and treatment. The present investigation identified Sideroflexin 3 (SFXN3) as a possible prognostic biomarker in AML by integrating...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2026-04-01
|
| Serier: | Translational Oncology |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S1936523326000422 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
